A Multi-center, Randomized, Double-blind, Parallel Phase Ⅳ Study to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Choline fenofibrate (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Daewon Pharmaceutical
Most Recent Events
- 10 Sep 2021 Results (n=133; from July 2018 to December 2019) assessing efficacy and safety of a combination of choline fenofibrate and statin compared with statin monotherapy in patients with elevated TG and controlled LDL-C levels, published in the Clinical Therapeutics.
- 19 Mar 2019 New trial record